Ozempic is a GLP-1 receptor agonist that doctors prescribe off-label for weight loss. Mounjaro is a GIP and GLP-1 agonist that most observers expect to become FDA-approved for weight loss. Further studies are needed to compare the effectiveness of the medications, but Mounjaro simulates the effects of more hormones than Ozempic and may lead to greater weight loss.